Frank Takkinen
Stock Analyst at Lake Street
(0.92)
# 3,969
Out of 5,156 analysts
75
Total ratings
26.47%
Success rate
-15.96%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $20.88 | +139.46% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.43 | +246.42% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.96 | -29.44% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $10.87 | +267.99% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.61 | +73.54% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $4.09 | +193.40% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $29.28 | +36.61% | 2 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.99 | +305.76% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $0.91 | +231.20% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.82 | +119.78% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.17 | +412.82% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $2 | $1.16 | +72.41% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $61.89 | +142.37% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.78 | +122.63% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $7.86 | +78.12% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.89 | +26.16% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $14.93 | +74.15% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $11.54 | +159.97% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.93 | +237.27% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.65 | +203.03% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $36.09 | -16.87% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.68 | +783.13% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.07 | +93.24% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $14.03 | -14.47% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.43 | +162.39% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.13 | +287.88% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $10.61 | +2,509.80% | 2 | Jan 18, 2023 |
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $20.88
Upside: +139.46%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.43
Upside: +246.42%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.96
Upside: -29.44%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $10.87
Upside: +267.99%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.61
Upside: +73.54%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $4.09
Upside: +193.40%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $29.28
Upside: +36.61%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.99
Upside: +305.76%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.91
Upside: +231.20%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.82
Upside: +119.78%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.17
Upside: +412.82%
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.16
Upside: +72.41%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $61.89
Upside: +142.37%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.78
Upside: +122.63%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.86
Upside: +78.12%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.89
Upside: +26.16%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $14.93
Upside: +74.15%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.54
Upside: +159.97%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.93
Upside: +237.27%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.65
Upside: +203.03%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $36.09
Upside: -16.87%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.68
Upside: +783.13%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.07
Upside: +93.24%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $14.03
Upside: -14.47%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.43
Upside: +162.39%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.13
Upside: +287.88%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $10.61
Upside: +2,509.80%